Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.644
Peer-review started: April 10, 2020
First decision: September 21, 2020
Revised: October 29, 2020
Accepted: November 11, 2020
Article in press: November 11, 2020
Published online: December 15, 2020
Coronavirus disease 2019 (COVID-19) is a pandemic disease that results in more than one million deaths. Diabetes is one of the most common comorbidities in COVID-19 patients and possibly increases mortality in patients.
Diabetic patients tend to develop into severe status, leading to poor prognosis. The importance of glycemic control needs to be emphasized.
We attempted to clarify the relationship between diabetes and patients’ severity at the beginning of the pandemic.
The clinical characteristics of 61 consecutive patients diagnosed with COVID-19 were collected. The logistic regression was used to calculate ORs of patients’ severity status-related factors.
Diabetes (OR = 6.29, P = 0.016) and hepatic dysfunction (OR = 5.88, P = 0.018) were independent risk factors for severe disease status in COVID-19 patients in multivariate logistic regression. Poor control of blood glucose (BG) can be seen in diabetic patients.
In this article, we give evidence on the relationship of diabetes and hepatic dysfunction with patients’ severity in COVID-19 patients. Based on the fact that patients' BG was not well-managed, we appeal to the optimized strategies for diabetes patients with COVID-19.
Attention should be paid to BG management.